血府逐瘀汤联合干扰素治疗慢性乙型肝炎肝纤维化对症状及血液相关指标影响

目的：观察探讨应用血府逐瘀汤联合干扰素治疗慢性乙型肝炎肝纤维化的临床疗效。方法：选取我院收纳的100例慢性乙型肝炎肝纤维化患者，平均分为观察组和对照组，分别给予干扰素治疗及加用血府逐瘀汤治疗，对比两组患者治疗效果。结果：观察组总有效率比对照组高，具有统计学意义。结论：应用血府逐瘀汤联合干扰素治疗慢性乙型肝炎肝纤维化疗效显著，值得临床上进一步推广应用。

Objective ： to observe to explore application of combined interferon therapeutic clinical curative effect for the treatment of liver fibrosis in chronic hepatitis b. Methods ： choose 100 cases received liver fibrosis of chronic hepatitis b patients, divided into observation group and control group, were given interferon therapeutic drugs and treatment, compared two groups of patients with therapeutic effect. Results： the observation group total effective rate is higher than control group, with statistical significance. Conclusion ： the application of combined interferon therapeutic liver fibrosis of chronic hepatitis b with obvious therapeutic effect, is worth further clinical application.